Raleigh Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
BCM
TWM
EFG
AFWM
PFA
QA
Raleigh Capital Management's BTAL Position: Q4 2022 in Review
Raleigh Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2022, closing a stake of 150 shares — an estimated $3K sold.
Raleigh Capital Management first reported a position in BTAL in Q4 2021 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 80 funds tracked by Wall St. Rank hold BTAL as of Q4 2022.
- Raleigh Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2022 after selling out during the quarter.
- Raleigh Capital Management sold 150 AGF US Market Neutral Anti-Beta Fund shares in Q4 2022, an estimated $3K.
- Raleigh Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and held it in 4 quarters.
- Raleigh Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4K in Q2 2022.
- 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2022.
Based on Raleigh Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.